While a causal relationship between this deficiency of PPAR-γ and the heightened state of inflammation that characterizes sarcoidosis is plausible, the effects of PPAR-γ agonist administration or factors known to upregulate PPAR-γ expression on disease course remain to be investigated. This evidence concerns the gene PPARG and sarcoidosis.